Koninklijke DSM (OTCMKTS:RDSMY) Downgraded to Underperform at Sanford C. Bernstein

Share on StockTwits

Koninklijke DSM (OTCMKTS:RDSMY) was downgraded by stock analysts at Sanford C. Bernstein from a “market perform” rating to an “underperform” rating in a research note issued on Tuesday, The Fly reports.

A number of other research firms also recently issued reports on RDSMY. Morgan Stanley reaffirmed an “equal weight” rating on shares of Koninklijke DSM in a report on Wednesday, October 14th. Credit Suisse Group reaffirmed a “neutral” rating on shares of Koninklijke DSM in a report on Wednesday, November 4th. Zacks Investment Research raised shares of Koninklijke DSM from a “hold” rating to a “buy” rating and set a $49.00 price objective for the company in a report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Koninklijke DSM in a report on Tuesday, November 10th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. Koninklijke DSM has a consensus rating of “Hold” and an average target price of $49.00.

Shares of OTCMKTS:RDSMY opened at $44.07 on Tuesday. The firm has a fifty day moving average price of $42.26 and a two-hundred day moving average price of $40.34. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.09 and a quick ratio of 1.30. Koninklijke DSM has a one year low of $22.86 and a one year high of $44.71. The company has a market cap of $31.98 billion, a price-to-earnings ratio of 44.97, a PEG ratio of 3.12 and a beta of 0.96.

Koninklijke DSM (OTCMKTS:RDSMY) last posted its quarterly earnings data on Tuesday, November 3rd. The basic materials company reported $0.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.01). Koninklijke DSM had a return on equity of 10.20% and a net margin of 6.97%. The company had revenue of $2.29 billion for the quarter. Equities research analysts expect that Koninklijke DSM will post 1.32 EPS for the current fiscal year.

Koninklijke DSM Company Profile

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments.

See Also: Dead Cat Bounce

The Fly

Analyst Recommendations for Koninklijke DSM (OTCMKTS:RDSMY)

Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.